Richard L Palmer, MD | |
1328 Southern Ave Se, Suite 310, Washington, DC 20032-4689 | |
(202) 562-0400 | |
(202) 562-8619 |
Full Name | Richard L Palmer |
---|---|
Gender | Male |
Speciality | Internal Medicine |
Experience | 34 Years |
Location | 1328 Southern Ave Se, Washington, District Of Columbia |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1134206741 | NPI | - | NPPES |
0771 0007 | Other | BLUE CHOICE | |
034639100 | Medicaid | DC | |
0771 0007 | Other | DC | CAREFIRST |
92500 | Other | AMERIGROUP | |
517465 | Other | MDIPA/OPTIMUM CHOICE | |
17082 | Other | CHARTERED | |
1965 | Other | ELDER HEALTH |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RN0300X | Internal Medicine - Nephrology | MD31979 (District Of Columbia) | Primary |
207RN0300X | Internal Medicine - Nephrology | D0055120 (Maryland) | Secondary |
Facility Name | Location | Facility Type |
---|---|---|
Whitney Dialysis Llc | Oxon hill, MD | Dialysis facility |
Medstar Southern Maryland Hospital Center | Clinton, MD | Hospital |
Medstar Washington Hospital Center | Washington, DC | Hospital |
Adventist Healthcare Fort Washington Medical Ctr | Fort washington, MD | Hospital |
United Medical Center | Washington, DC | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Capital Area Renal Associates, Pc | 2365421856 | 7 |
News Archive
Ruthigen, Inc., today announced that it has treated the first human subjects with its leading drug candidate RUT58-60 in a 30 patient, 21-day skin irritation trial, which is expected to be completed in August 2014.
Wellmont Health System and HealthSouth Corporation (NYSE: HLS) today announced that a joint venture entity formed by the two parties has been awarded a certificate of public need (COPN) to open a new inpatient rehabilitation hospital in Bristol, Va. The 25-bed hospital will enable more patients in Bristol and throughout Southwest Virginia to have access to comprehensive, high-quality rehabilitative services.
Play the same piece of music to two people, and their hearts can respond very differently. That's the conclusion of a novel study presented today on EHRA Essentials 4 You, a scientific platform of the European Society of Cardiology (ESC).
PharmaIN Corporation and LAT Pharma LLC today announced that the US Food and Drug Administration (FDA) has granted their request for orphan-drug designation for terlipressin for the treatment of ascites due to all etiologies except for cancer.
Omega 3 fatty acids in dietary fish oil are reported to have anti-inflammatory and anti-thrombogenic and anti-arrhythmic effects in humans, but the biochemical basis for these beneficial health effects is not well understood.
› Verified 9 days ago
Entity Name | Capital Area Renal Associates, Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1871641365 PECOS PAC ID: 2365421856 Enrollment ID: O20040719000082 |
News Archive
Ruthigen, Inc., today announced that it has treated the first human subjects with its leading drug candidate RUT58-60 in a 30 patient, 21-day skin irritation trial, which is expected to be completed in August 2014.
Wellmont Health System and HealthSouth Corporation (NYSE: HLS) today announced that a joint venture entity formed by the two parties has been awarded a certificate of public need (COPN) to open a new inpatient rehabilitation hospital in Bristol, Va. The 25-bed hospital will enable more patients in Bristol and throughout Southwest Virginia to have access to comprehensive, high-quality rehabilitative services.
Play the same piece of music to two people, and their hearts can respond very differently. That's the conclusion of a novel study presented today on EHRA Essentials 4 You, a scientific platform of the European Society of Cardiology (ESC).
PharmaIN Corporation and LAT Pharma LLC today announced that the US Food and Drug Administration (FDA) has granted their request for orphan-drug designation for terlipressin for the treatment of ascites due to all etiologies except for cancer.
Omega 3 fatty acids in dietary fish oil are reported to have anti-inflammatory and anti-thrombogenic and anti-arrhythmic effects in humans, but the biochemical basis for these beneficial health effects is not well understood.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Richard L Palmer, MD 7801 Old Branch Ave, Suite 409, Clinton, MD 20735-1608 Ph: (301) 868-7121 | Richard L Palmer, MD 1328 Southern Ave Se, Suite 310, Washington, DC 20032-4689 Ph: (202) 562-0400 |
News Archive
Ruthigen, Inc., today announced that it has treated the first human subjects with its leading drug candidate RUT58-60 in a 30 patient, 21-day skin irritation trial, which is expected to be completed in August 2014.
Wellmont Health System and HealthSouth Corporation (NYSE: HLS) today announced that a joint venture entity formed by the two parties has been awarded a certificate of public need (COPN) to open a new inpatient rehabilitation hospital in Bristol, Va. The 25-bed hospital will enable more patients in Bristol and throughout Southwest Virginia to have access to comprehensive, high-quality rehabilitative services.
Play the same piece of music to two people, and their hearts can respond very differently. That's the conclusion of a novel study presented today on EHRA Essentials 4 You, a scientific platform of the European Society of Cardiology (ESC).
PharmaIN Corporation and LAT Pharma LLC today announced that the US Food and Drug Administration (FDA) has granted their request for orphan-drug designation for terlipressin for the treatment of ascites due to all etiologies except for cancer.
Omega 3 fatty acids in dietary fish oil are reported to have anti-inflammatory and anti-thrombogenic and anti-arrhythmic effects in humans, but the biochemical basis for these beneficial health effects is not well understood.
› Verified 9 days ago
Dr. Adefolaju Oketokun, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1629 K Street Nw, Suite 300, Washington, DC 20006 Phone: 202-636-1360 Fax: 202-636-5137 | |
Dr. Uzoamaka Theodora Nwaogwugwu, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2041 Georgia Avenue Nw, Washington, DC 20060 Phone: 202-865-7677 | |
Ms. Sruthi Nukalapati Reddy, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3800 Reservoir Road Nw, 6 Phc, Washington, DC 20007 Phone: 202-444-8123 | |
Dr. Kaustubh Subhash Yadwadkar, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3800 Reservoir Rd Nw, Cg201, Washington, DC 20007 Phone: 304-206-7595 | |
Dr. Monica Vohra, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1525 7th St Nw, Washington, DC 20001 Phone: 202-386-7020 Fax: 202-265-1970 | |
Anteneh A Tesfaye, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 110 Irving St Nw Ste C2151, Washington, DC 20010 Phone: 202-877-6998 Fax: 202-877-8909 | |
Erica Nakajima, Nephrology Medicare: Accepting Medicare Assignments Practice Location: 5255 Loughboro Rd Nw Fl 1, Washington, DC 20016 Phone: 202-660-6500 |